Medinotec Inc Financials
This page shows Medinotec Inc (MDNC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Medinotec Inc has an operating margin of 35.0%, meaning the company retains $35 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 12.0% the prior year.
Medinotec Inc's revenue surged 81.5% year-over-year to $9.1M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Medinotec Inc carries a low D/E ratio of 0.59, meaning only $0.59 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 4.27, Medinotec Inc holds $4.27 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 84/100.
Medinotec Inc has a free cash flow margin of 8.7%, earning a moderate score of 47/100. The company generates positive cash flow after capital investments, but with room for improvement.
Medinotec Inc earns a strong 50.6% return on equity (ROE), meaning it generates $51 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100. This is up from -18.7% the prior year.
Medinotec Inc passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Medinotec Inc generates $0.41 in operating cash flow ($878K OCF vs $2.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Medinotec Inc earns $18.1 in operating income for every $1 of interest expense ($3.2M vs $176K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Medinotec Inc generated $9.1M in revenue in fiscal year 2025. This represents an increase of 81.5% from the prior year.
Medinotec Inc's EBITDA was $3.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 374.1% from the prior year.
Medinotec Inc reported $2.2M in net income in fiscal year 2025. This represents an increase of 633.6% from the prior year.
Cash & Balance Sheet
Medinotec Inc generated $789K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 6480.6% from the prior year.
Medinotec Inc held $2.8M in cash against $0 in long-term debt as of fiscal year 2025.
Medinotec Inc had 12M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
Medinotec Inc's gross margin was 53.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.7 percentage points from the prior year.
Medinotec Inc's operating margin was 35.0% in fiscal year 2025, reflecting core business profitability. This is up 23.1 percentage points from the prior year.
Medinotec Inc's net profit margin was 23.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 31.8 percentage points from the prior year.
Medinotec Inc's ROE was 50.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 69.2 percentage points from the prior year.
Capital Allocation
Medinotec Inc invested -$91K in research and development in fiscal year 2025. This represents a decrease of 307.7% from the prior year.
Medinotec Inc invested -$89K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3847.4% from the prior year.
MDNC Income Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5M-21.6% | $3.2M+51.7% | $2.1M-38.9% | $3.5M+36.2% | $2.6M+42.2% | $1.8M+44.1% | $1.3M-44.4% | $2.3M |
| Cost of Revenue | $1.2M-3.5% | $1.2M+202.1% | -$1.2M+80.2% | -$6.1M-499.9% | $1.5M+57.0% | $971K+249.0% | -$652K+82.3% | -$3.7M |
| Gross Profit | $1.3M-32.8% | $2.0M+116.4% | $925K-61.2% | $2.4M+129.3% | $1.0M+24.9% | $833K+38.8% | $600K-38.2% | $971K |
| R&D Expenses | $8K-87.4% | $66K+235.1% | -$49K+66.7% | -$147K-312.7% | $69K+3561.2% | $2K+112.6% | -$15K+56.8% | -$35K |
| SG&A Expenses | $435K-40.0% | $725K+227.4% | -$570K+69.2% | -$1.8M-587.0% | $379K+7.2% | $354K+227.6% | -$277K+87.3% | -$2.2M |
| Operating Income | $553K+4.6% | $529K+90.5% | $277K-85.8% | $2.0M+271.4% | $527K+21.0% | $436K+61.9% | $269K+9.4% | $246K |
| Interest Expense | $7K-82.3% | $40K+26.2% | $32K+109.8% | -$325K-848.7% | $43K-7.8% | $47K-18.8% | $58K+178.3% | -$74K |
| Income Tax | $139K-28.2% | $194K+30.2% | $149K+111.7% | -$1.3M-844.0% | $171K+54.6% | $111K-12.8% | $127K+155.6% | -$228K |
| Net Income | $403K+16.4% | $347K+204.6% | $114K-92.3% | $1.5M+376.0% | $310K+9.0% | $285K+226.5% | $87K-11.5% | $99K |
| EPS (Diluted) | N/A | $0.03+200.0% | $0.01 | N/A | N/A | $0.02+100.0% | $0.01 | N/A |
MDNC Balance Sheet
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.9M+7.5% | $6.4M-13.9% | $7.4M+8.7% | $6.8M+27.0% | $5.4M+1.3% | $5.3M+22.5% | $4.3M-10.0% | $4.8M |
| Current Assets | $6.5M+8.3% | $6.0M-14.0% | $7.0M+8.3% | $6.4M+30.5% | $4.9M+0.4% | $4.9M+24.6% | $3.9M-10.1% | $4.4M |
| Cash & Equivalents | $2.9M+27.1% | $2.2M+15.2% | $2.0M-29.6% | $2.8M+3.5% | $2.7M-3.0% | $2.8M+9.5% | $2.5M-10.3% | $2.8M |
| Inventory | $921K+24.2% | $742K+13.2% | $655K-10.5% | $732K-37.0% | $1.2M-9.4% | $1.3M+34.0% | $957K+68.0% | $570K |
| Accounts Receivable | $2.3M-12.3% | $2.6M-33.7% | $3.9M+48.8% | $2.6M+163.2% | $992K+28.7% | $771K+115.1% | $359K-39.2% | $590K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.4M-11.8% | $1.5M-49.4% | $3.0M+19.6% | $2.5M+0.1% | $2.5M-8.3% | $2.8M+33.5% | $2.1M-21.4% | $2.6M |
| Current Liabilities | $1.4M-11.9% | $1.5M-26.6% | $2.1M+38.9% | $1.5M+2.0% | $1.5M-5.8% | $1.6M+102.9% | $772K-6.7% | $827K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $5.5M+13.7% | $4.8M+10.7% | $4.4M+2.3% | $4.3M+51.1% | $2.8M+11.7% | $2.5M+12.4% | $2.3M+3.8% | $2.2M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MDNC Cash Flow Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $563K-54.0% | $1.2M+261.2% | -$759K-869.1% | $99K-20.7% | $125K-69.5% | $408K+65.9% | $246K+383.0% | -$87K |
| Capital Expenditures | N/A | N/A | N/A | -$179K-347.0% | $73K+205.3% | $24K+492.9% | -$6K-331.3% | -$1K |
| Free Cash Flow | N/A | N/A | N/A | -$81K-255.5% | $52K-86.5% | $385K+60.2% | $240K+371.7% | -$88K |
| Investing Cash Flow | N/A | N/A | N/A | $1K+101.9% | -$73K-521.9% | -$12K-92.9% | -$6K-155.2% | $11K |
| Financing Cash Flow | -$3K+99.7% | -$943K-2387.0% | -$38K+25.6% | -$51K+53.6% | -$110K+43.0% | -$192K+64.5% | -$542K-297.3% | $274K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MDNC Financial Ratios
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.1%-8.8pp | 61.9%+18.5pp | 43.4%-25.0pp | 68.3%+27.7pp | 40.6%-5.6pp | 46.2%-1.7pp | 47.9%+4.8pp | 43.1% |
| Operating Margin | 21.8%+5.5pp | 16.3%+3.3pp | 13.0%-43.1pp | 56.1%+35.5pp | 20.6%-3.6pp | 24.1%+2.6pp | 21.5%+10.6pp | 10.9% |
| Net Margin | 15.9%+5.2pp | 10.7%+5.4pp | 5.3%-37.0pp | 42.3%+30.2pp | 12.1%-3.7pp | 15.8%+8.8pp | 7.0%+2.6pp | 4.4% |
| Return on Equity | 7.3%+0.2pp | 7.2%+4.6pp | 2.6%-32.0pp | 34.6%+23.6pp | 11.0%-0.3pp | 11.3%+7.4pp | 3.9%-0.7pp | 4.5% |
| Return on Assets | 5.9%+0.5pp | 5.4%+3.9pp | 1.5%-20.2pp | 21.7%+15.9pp | 5.8%+0.4pp | 5.4%+3.4pp | 2.0%-0.0pp | 2.1% |
| Current Ratio | 4.79+0.9 | 3.90+0.6 | 3.33-0.9 | 4.27+0.9 | 3.34+0.2 | 3.13-2.0 | 5.10-0.2 | 5.29 |
| Debt-to-Equity | 0.25-0.1 | 0.32-0.4 | 0.69+0.1 | 0.59-0.3 | 0.90-0.2 | 1.09+0.2 | 0.92-0.3 | 1.22 |
| FCF Margin | N/A | N/A | N/A | -2.3%-4.3pp | 2.0%-19.3pp | 21.3%+2.1pp | 19.2%+23.1pp | -3.9% |
Frequently Asked Questions
What is Medinotec Inc's annual revenue?
Medinotec Inc (MDNC) reported $9.1M in total revenue for fiscal year 2025. This represents a 81.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Medinotec Inc's revenue growing?
Medinotec Inc (MDNC) revenue grew by 81.5% year-over-year, from $5.0M to $9.1M in fiscal year 2025.
Is Medinotec Inc profitable?
Yes, Medinotec Inc (MDNC) reported a net income of $2.2M in fiscal year 2025, with a net profit margin of 23.7%.
What is Medinotec Inc's EBITDA?
Medinotec Inc (MDNC) had EBITDA of $3.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Medinotec Inc's gross margin?
Medinotec Inc (MDNC) had a gross margin of 53.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Medinotec Inc's operating margin?
Medinotec Inc (MDNC) had an operating margin of 35.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Medinotec Inc's net profit margin?
Medinotec Inc (MDNC) had a net profit margin of 23.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Medinotec Inc's return on equity (ROE)?
Medinotec Inc (MDNC) has a return on equity of 50.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Medinotec Inc's free cash flow?
Medinotec Inc (MDNC) generated $789K in free cash flow during fiscal year 2025. This represents a 6480.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Medinotec Inc's operating cash flow?
Medinotec Inc (MDNC) generated $878K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Medinotec Inc's total assets?
Medinotec Inc (MDNC) had $6.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Medinotec Inc's capital expenditures?
Medinotec Inc (MDNC) invested -$89K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Medinotec Inc's current ratio?
Medinotec Inc (MDNC) had a current ratio of 4.27 as of fiscal year 2025, which is generally considered healthy.
What is Medinotec Inc's debt-to-equity ratio?
Medinotec Inc (MDNC) had a debt-to-equity ratio of 0.59 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Medinotec Inc's return on assets (ROA)?
Medinotec Inc (MDNC) had a return on assets of 31.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Medinotec Inc's Piotroski F-Score?
Medinotec Inc (MDNC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Medinotec Inc's earnings high quality?
Medinotec Inc (MDNC) has an earnings quality ratio of 0.41x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Medinotec Inc cover its interest payments?
Medinotec Inc (MDNC) has an interest coverage ratio of 18.1x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Medinotec Inc?
Medinotec Inc (MDNC) scores 87 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.